A survey of aspirin use for vascular prophylaxis in Wales

Authors: Elwood, Peter; Hughes, Janie; Morgan, Gareth; Brown, Ginevra; Longley, Marcus

Source: Quality in Primary Care, Volume 13, Number 4, December 2005 , pp. 201-204(4)

Publisher: Radcliffe Publishing Ltd.

Buy & download fulltext article:


Price: $20.00 plus tax (Refund Policy)


Aspirin is of little interest to pharmaceutical companies and it therefore appears to receive relatively little promotion in vascular prophylaxis. A survey of aspirin taking by patients known to be at high vascular risk was therefore conducted in 12 general medical practices across Wales. Random samples of approximately 25 patients within each of six diagnostic groups associated with high vascular risk were selected within each practice. These patients were then written to and asked what drugs they were taking regularly. Questionnaire responses were obtained from 1386 patients (85% of those contacted). Overall, only 53% of patients stated they were taking aspirin regularly. This finding provides evidence that low-dose prophylactic aspirin is poorly used by patients at high vascular risk in Wales. There is therefore an urgent need for the vigorous promotion of the drug for this indication.


Document Type: Regular Paper

Publication date: December 1, 2005

More about this publication?
Related content



Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page